Abstract:Introduction The neuroticism personality trait plays an important role in the etiology of major depressive disorder. Our previous study suggested that different neural mechanisms drive unique brain morphology changes in individuals with late-life depression and high neuroticism (LLD_HN) compared with those with LLD and low neuroticism (LLD_LN). We found that LLD_HN had smaller volume in the frontal pole than LLD_LN and never-depressed control subjects, whereas LLD_LN had higher volumes of non-white matter hypo-intensities in the cingulate and basal ganglia area, which suggests differences in pathology of LLD with and without neuroticism. We theorized that LLD_LN might be related to microvascular damages (vascular depression), although the pathology of LLD_HN would be more complex and involve frontal lobe structure and function. To support this hypothesis, we measured cerebral blood flow (CBF) using arterial spin labeling (ASL) images from the same study groups. We aimed to validate the prefrontal dysfunction theory in LLD_HD versus the vascular depression theory in LLD_LD. We hypothesized that compared to LLD_LN and never depressed groups, the LLD_HN group would have significantly decreased CBF in the frontal pole, whereas the LLD_LN group would have significantly decreased CBF in the basal ganglia regions. Methods This study used data from the NIMH-funded Neurobiology of Late-life Depression (NBOLD) project. The NBOLD study was approved by the Institutional Review Boards of the University of Connecticut Health Center (UCHC) and Hartford Hospital (IE-13-048H-6.1). All subjects consented prior to participation. Clinical and imaging data from 55 subjects with LLD and 8 never-depressed healthy control (HC) subjects were used in this analysis. The primary measures of the study were neuroticism and depression symptoms, which were assessed using the NEO Personality Inventory (NEO-PI) and the Montgomery - Asberg Depression Rating Scale (MADRS), respectively. Using a baseline neuroticism median score of 109.5, we divided LLD subjects into LLD_LN (n = 26) and LLD_HN (n = 26) subgroups. The mean age of all subjects was 72, and subjects were 70% female and 90% white. Subjects were scanned using a Skyra 3T scanner (Siemens, Erlangen, Germany) with 32 surface coils at the Olin Neuropsychiatry Research Center (ONRC) at the Institute of Living. Five high-resolution axial T1-weighted MPRAGE images were acquired parallel with the AC-PC line. The acquisition parameters were TR/TE = 2200/2.88 ms, flip angle = 13°, matrix = 220 × 320 × 208, and voxel size = 0.8 × 0.8 × 0.8 mm3. The pCASL EPI 2D sequence was employed to acquire the ASL images using the following parameters: TR/TE = 4000/13 ms, flip angle = 90°, voxel size = 3.4 × 3.4 × 5 mm3, TI = 1.8 s, and number of phase encoding steps = 48. FSL BASIL software was used to conduct ASL data preprocessing and individual data analysis. FLAMO was used for whole-brain voxel-wise group level data analysis using one-way ANOVA to examine group differences in perfusion. The significance threshold was set at p < 0.05 with GRF cluster correction. Significant clusters were extracted as ROIs for post hoc t-test to compare regional perfusion between two of the three group differences. All data analysis were conducted using age, gender, education, and MADRS as covariates. Results There was no significant group difference in perfusion based on age, gender, or education, nor in depression severity between the two depressed groups. ANOVA analysis revealed a significant group effect in the left putamen and thalamus. ROI analyses revealed that the group effect was significant in the left putamen (p = 0.0038) and in the left thalamus (p = 0.033). Post hoc pairwise comparisons showed that the mean CBF for both the LLD_HN and the LLD_LN group was significantly lower in the left putamen (p = 0.0048 and 0.0009 respectively) and left thalamus (LN, p = 0.0093; HN, p = 0.0524). Although the mean CBF value of both regions for the LLD_LN was lower than that for the LLD_HN, the difference in CBF between the two LLD groups at either left putamen or thalamus was not statistically significant (putamen, p = 0.3442; thalamus, p = 0.3040). Controlling for age, gender, and the depression severity (MADRS) did not impact the results. We further conducted regression analysis in the LLD group combining the LLD_HD and LLD_LD to examine the correlation between neuroticism score and CBF in the left putamen, thalamus, and frontal pole. Only the left putamen showed a significant correlation between neuroticism and CBF (r = 0.28, p = 0.04). Conclusions We found significantly lower CBF in the left putamen and thalamus in both LLD group -Abstract Truncated-

Contribution of neuroimaging in late-life depression

Brain-based mechanisms of late-life depression: Implications for novel interventions

Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares

Cerebral Volume Measurements and Subcortical White Matter Lesions and Short‐term Treatment Response in Late Life Depression

Advances and Barriers for Clinical Neuroimaging in Late-Life Mood and Anxiety Disorders

Association between change in brain gray matter volume, cognition, and depression severity: Pre- and post- antidepressant pharmacotherapy for late-life depression

Neuroimaging studies of fronto-limbic dysfunction in geriatric depression

Neural Functioning in Late-Life Depression: An Activation Likelihood Estimation Meta-Analysis

Brain morphometric features predict depression symptom phenotypes in late-life depression using a deep learning model

Anxiety in late-life depression: Associations with brain volume, amyloid beta, white matter lesions, cognition, and functional ability

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Brain grey matter volume alterations in late-life depression.

Cortico-limbic volume abnormalities in late life depression are distinct from β amyloid and white matter pathologies

Molecular Basis of Late-Life Depression

Automatic diagnosis of late-life depression by 3D convolutional neural networks and cross-sample Entropy analysis from resting-state fMRI

Relationship between cognition, magnetic resonance white matter hyperintensities, and cardiovascular autonomic changes in late-life depression

Machine Learning Prediction of Treatment Outcome in Late-Life Depression

Microstructural brain assessment in late-life depression and apathy using diffusion MRI multi-compartments models and tractometry

Cerebral Blood Flow Changes and Neuroticism in Late-Life Depression

Influences of resting-state intrinsic functional brain connectivity on the antidepressant treatment response in late-life depression

Abnormal Voxel-Wise Degree Centrality in Patients With Late-Life Depression: A Resting-State Functional Magnetic Resonance Imaging Study